SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing a significant surge following positive topline results from a Phase 3 trial of its personalized mRNA cancer vaccine, marking the first successful late-stage trial of its kind. The community is actively debating the stock's massive upside potential and the broader implications for oncology, with polarized discussions between bulls celebrating the scientific breakthrough and skeptics questioning the sustainability of the price move and the long-term safety profile of mRNA therapies.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending following a landmark commercial agreement and warrant deal with Alphabet that positions the company as a key custom chip partner for the Google TPU ecosystem. Investors are actively debating the long-term growth potential and revenue visibility provided by this strategic partnership, with many closely monitoring how the warrant structure and potential equity stake will influence the stock's valuation and sector competitiveness.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is experiencing significant selling pressure driven by concerns over its off-balance-sheet financing vehicles and VMware security vulnerabilities. While the community is debating whether this pullback is an overreaction to market noise or a structural re-rating of the stock ahead of earnings, many retail traders are actively looking to buy the dip, viewing the current price as a discount on a fundamentally strong AI infrastructure leader.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending as investors monitor macro-economic shifts and anticipate regulatory clarity from upcoming government crypto summits. The community remains divided, with bulls highlighting institutional accumulation and liquidity injections, while bears express skepticism about the asset's volatility and market independence.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The iShares 20+ Year Treasury Bond ETF (TLT) is trending as the Treasury Department doubles its buyback operation size to $4 billion to provide liquidity and stabilize long-term debt markets. Investors are actively debating whether this move acts as a necessary support for bond yields or a form of 'backdoor QE' that complicates the inflation outlook as they closely monitor upcoming Fed minutes and ongoing geopolitical pressures.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is trending as markets react to the U.S. Treasury announcing an expansion of its long-term bond buyback program to stabilize liquidity and mitigate recent volatility in Treasury yields. While this intervention has triggered a short-term relief rally in equity futures, market participants remain highly divided, with many debating whether this is a temporary band-aid for structural debt issues or a signal of deeper systemic stress.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant upward momentum as investors speculate on a potential short squeeze, with short interest remaining elevated above 30 percent. The community is actively discussing the stock's role in the AI-driven precision medicine sector, with many highlighting its strategic data platform and recent performance as key reasons for continued bullish sentiment.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors react to positive sector-wide developments in cancer vaccine efficacy, fueling optimism about the potential validation of the GPS platform and a significant valuation re-rating. The community is actively debating the timing of the REGAL phase 3 readout and the likelihood of institutional accumulation or a strategic acquisition as the company approaches key data milestones.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is currently trending as investors debate whether the stock is being unfairly suppressed by algorithmic trading and short-selling pressure or suffering from poor management execution compared to sector peers. The community is sharply divided between "diamond-handed" investors accumulating shares at what they perceive as a deep discount and skeptical traders who view recent price action as a failing setup following underwhelming post-contract performance.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending as investor focus shifts to its oncology pipeline and strategic M&A potential following key trial successes and the looming patent expiration for Keytruda. The community is actively debating speculative buyout targets and evaluating the company's ability to maintain its market dominance through new cancer combination therapies.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SCNX [RSS] The Company has until 10/12 to re-gain compliance with Nasdaq minimum Bid requirement.  If the stock surges over $1.0 in the interim for the requisite (10d) trading period, investors here will have all 2X their money and SCNX compliance re-instated.  If/where the stock continues to trade here, the Company will announce an RSS, likely 15:1 (IMO) that will place the stock price above the $5.0 penny stock threshold for broader institutional investment, while reducing the float to 2.1M approximately.  Either situation (IMO) provides a material benefit to those invested at/around these levels.  Arbli is scaling into the established network infrastructure at 97% GM, Rezenopy just launched into commercialization with the same infrastructure and larger addressable market - the Company has near-term liquidity with expectations of profitability by 2027. IP secured on both until 2041.   Revenue scaling on both drugs, comparable GM provides the Company a good opportunity to that end.

Dale

Ottersberger

Shaun Neynens

Cindy

StockTwits Web

Scienture Holdings Inc.

 [RSS] The Company has until 10/12 to re-gain compliance with Nasdaq minimum Bid requirement.  If the stock surges over $1.0 in the interim for the requisite (10d) trading period, investors here will have all 2X their money and SCNX compliance re-instated.  If/where the stock continues to trade here, the Company will announce an RSS, likely 15:1 (IMO) that will place the stock price above the $5.0 penny stock threshold for broader institutional investment, while reducing the float to 2.1M approximately.  Either situation (IMO) provides a material benefit to those invested at/around these levels.  Arbli is scaling into the established network infrastructure at 97% GM, Rezenopy just launched into commercialization with the same infrastructure and larger addressable market - the Company has near-term liquidity with expectations of profitability by 2027. IP secured on both until 2041.   Revenue scaling on both drugs, comparable GM provides the Company a good opportunity to that end.

Matthew Joseph

@BinaryLogic Thank you for continuing to share your perspective on $SCNX .  Many of us value your opinion and your input regarding investment opportunities.  

If I recall correctly you used to follow $MIST closely. Do you have an updated opinion on the coverage they&#39;ve achieved, Rx numbers, and intermediate and/or long-term outlook based on their recent ER?

StockTwits For Android 

Milestone Pharmaceuticals Inc

 Thank you for continuing to share your perspective on 

 .  Many of us value your opinion and your input regarding investment opportunities.  

If I recall correctly you used to follow 

 closely. Do you have an updated opinion on the coverage they've achieved, Rx numbers, and intermediate and/or long-term outlook based on their recent ER?

@BinaryLogic which news will send it through 1$ within the short amount of time until 10/12?

StockTwits for iOS

 which news will send it through 1$ within the short amount of time until 10/12?